article · Slovenian Veterinary Research
Glycyrrhizc acid (GA) is one of the herbal plants with a proved hepato-protective effect. The current study was carried out to estimate the hepato-protective effect of GA against liver fibrosis and to disclose its mode of action. Thirty two male albino rats were randomly distributed into 4 groups (n=8), i.e., control group, GA group, CCl4 group and CCl4 + GA group. Liver enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), liver histopathology, malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CT) and gene expression of integrin subunit β like 1 (ITGBL1) were analyzed. The obtained data revealed that GA remarkably protected CCl4-induced liver injury as reflected by reduced AST, ALT, GGT, and fibrosis compared with the CCl4-only group. Moreover, GA significantly reduced the levels of MDA, as well as increased the activity of SOD and CT. Consequently, GA prevents CCl4-induced fibrosis in rats. The prophylactic action of GA against liver fibrosis was mediated through its antioxidant and anti-inflammatory activities. Additionally, GA downregulated fibrogenic ITGBL1.Key words: glycyrrhizc acid; ITGBL1; liver fibrosis; integrins
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.26873/svr-806-2019
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
